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Abstract
Background: Surgical site infections (SSIs) increase morbidity and mortality rates and generate additional cost
for the healthcare system. Pre-operative blood transfusion and the subcutaneous fat thickness (SFT) have been
described as risk factors for SSI in other surgical areas. The purpose of this study was to assess the impact of
pre-operative blood transfusion and the SFT on the occurrence of SSI in posterior thoracic spine surgery.
Methods: In total, 244 patients (median age 55 y; 97 female) who underwent posterior thoracic spine fusions
from 2008 to 2012 were reviewed retrospectively. Patient-specific characteristics, pre-operative hemoglobin
concentration/hematocrit values, the amount of blood transfused, and the occurrence of a post-operative SSI
were documented. The SFT was measured on pre-operative computed tomography scans.
Results: Surgical site infection was observed in 26 patients (11%). The SFT was 13mm in patients without SSI
and 14mm in those with infection (p= 0.195). The odds ratio for patients with pre-operative blood transfusion
to present with SSI was 3.1 (confidence interval [CI] 1.4–7.2) and 2.7 (CI 1.1–6.4) when adjusted for age. There
was no difference between the groups with regard to pre-operative hemoglobin concentration (p= 0.519) or
hematocrit (p = 0.908). The SFT did not differ in the two groups.
Conclusions: Allogeneic red blood cell transfusion within 48 h prior to surgery was an independent risk factor
for SSI after posterior fusion for the fixation of thoracic spine instabilities. Pre-operative blood transfusion
tripled the risk, whereas SFT had no influence on the occurrence of SSI.
Surgical site infections (SSIs) account for 38% of allhospital-acquired infections after surgery [1] and have
been linked to higher treatment costs and prolonged hospital
stays [2–4]. The rate of SSI after spinal surgery is reported to
range from 1% to 17% [4–8]. Factors such as diabetes mel-
litus, metastatic malignant disease, obesity, smoking, and
long duration of surgery appear to influence the occurrence of
incisional infections after spinal surgery [4,9].
Recently, two additional factors have been discussed. Mehta
et al. reported an association between subcutaneous fat thickness
(SFT) and SSIs after posterior cervical spine fusion surgery, this
being an independent risk factor [10]. In the cervical area, there
usually is a distinct layer of well-perfused musculature between
the skin and spine. However, in the thoracic spine, the combi-
nation of kyphosis and less soft tissue coverage leads to a closer
relation of bone (and implant) and skin. The first hypothesis
of this study was that there is a higher risk of infection after
posterior thoracic spine fusion in patients with a low SFT.
A purported association between pre-operative blood
transfusion and a higher rate of SSIs has been controversial
[11–15]. Some authors presume immuno-suppressive ef-
fects as a reaction to allogenic transfusions to be responsible
for a higher rate of malignant disease recurrence and nos-
ocomial infections [15–17]. The second hypothesis of this
study was that there is a higher risk of SSI if blood has been
transfused within 48 h prior to the intervention. Thus, the
aims of the study were to assess SFT and pre-operative
blood transfusion as potential independent risk factors for
SSI after posterior fusion for the fixation of thoracic spine
instabilities.
Patients and Methods
A single-center retrospective cohort study was conducted
at a university-level 1 trauma center through review of charts.
This study was approved by the local institutional ethics
Division of Trauma Surgery, University of Zurich, Zurich, Switzerland.
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committee (Kantonale Ethikkommission Zu¨rich; Ref. No.
2013-0293).
Patients
Two hundred eighty-eight consecutive patients aged ‡ 18 y
who were treated for thoracic spine instabilities by posterior
thoracic spine fusion between January 2008 and December
2012 were included in this study. Thoracic spine instabilities
comprised traumatic sequelae and pathologic fractures sec-
ondary to spinal metastases. Posterior thoracic spine fusion
was defined as an intervention that included or bridged at least
one injured thoracic segment. The standard intervention was
performed with the patient prone using a posterolateral ap-
proach to the thoracic spine with reposition and fixation of the
fracture by an internal fixateur (USS II, Synthes, Oberdorf,
Switzerland, or Legacy, Medtronic, Fridley, MN). If the au-
tologous bone harvested from the thoracic site was believed
not to be enough to achieve posterior fusion, additional allo-
graft (demineralized bone matrix) was applied. All patients
received intravenous single-dose antibiotic prophylaxis (ce-
fazolin) 30min prior to surgery. If necessary, allogeneic
transfusion management and treatment of a potential trauma-
associated coagulopathy during the hospital stay followed a
fixed algorithm [18].
The surgical algorithm emphasizes the use of anti-
fibrinolytics, point-of-care testing, and coagulation algo-
rithms with substitution of factor concentrates to allow a
reduction of allogeneic transfusion volume. According to
this algorithm, blood transfusion was given if the hemo-
globin concentration was < 70 g/L in healthy patients, < 80 g/L
in patients with increased risk under impaired oxygenation
(e.g., traumatic brain injury, coronary artery disease, age >80 y),
and < 90 g/L in patients with severe coronary artery disease
or severe heart failure.
Frequent routine follow-up included clinical assessment and
blood tests for inflammatory parameters in patients at risk. In
the case of pre-operative blood transfusion, hemoglobin and
hematocrit measurements were made after transfusion and
before surgery. Patients with pre-operative infection or revi-
sion surgery (n= 15); patients with missing records on history,
medication, transfusions during the hospital stay, and duration
of surgery (n= 0); and patients with an infection-free post-
operative follow-up of less < 30 d (n= 14) were excluded. In
addition, we excluded patients withmissing or insufficient pre-
operative computed tomography (CT) imaging, ‘‘insufficient’’
meaning that we were unable to measure SFT (n= 15). Finally,
244 patients (median age 55 y, range 18–91 y; 97 female) were
included.
Data Acquisition
Patient-specific and demographic characteristics with a
special focus on the presence of diabetes mellitus, pre-
operative local radiation therapy, an immunodeficiency
(human immunodeficiency virus, tuberculosis) or immuno-
suppressivemedication, pre-operative hemoglobin, amount of
pre-operative allogeneic red blood cell transfusions, and the
duration of surgery were documented.
Subcutaneous fat thickness was defined as the the distance
from the skin surface to themuscular fascia in themedian plane
on axial and sagittal views of pre-operative CT scans as de-
scribed previously for the cervical spine [10]. Measurements
were performed by one of the authors (LB). Each measurement
was repeated three times, and means were calculated. Post-
operative SSIwas said to be present in case of incision drainage
or the presence of an abscess with at least one positive culture,
as well as any delay in wound healing that was treated by
antibiotics or surgical revision.
Statistical Analysis
Statistical analysis was performed by an institutional stat-
istician. All data were recorded in an Excel database (Micro-
soft Corp., Washington, DC) and exported to SPSS 21.0 (IBM,
Inc., Armonk, NY) for analysis. Unless otherwise denoted,
data were summarized as the mean with the standard deviation
(SD).
The primary outcome was the occurrence of an SSI within
six wks after surgery. A regression analysis was performed
to assess ‘‘subcutaneous fat thickness’’ and ‘‘pre-operative
blood transfusion’’ as potential independent risk factors for
SSI. To detect potential confounders such as age, diabetes
mellitus, pre-operative local radiation therapy, immuno-
deficiency, immunosuppressive medication, number of in-
strumented spinal segments, and the duration of surgery,
crosstabs were associated. Where applicable, nominal vari-
ables crosstabs were associated using w2 or Fisher exact tests.
Because the variables exhibited somewhat non-normal dis-
tributions, a nonparametric analysis (Mann-Whitney U test)
was used to compare continuous data. In the case of a sig-
nificant association, this variable was further analyzed by
regression. To determine the prognostic value of SFT and
pre-operative blood transfusion, an odds ratio with a confi-
dence interval (CI) of 95% was calculated, and a receiver-
operating characteristic curve (ROC) analysis was generated
with calculation of the area under the curve (c statistic). To
test for potential autocorrelation, cases were sorted by date
of surgery and tested for randomness using a Wald-Wolfo-
witz test. The level of significance was defined as p < 0.05.
Results
Surgical site infection was observed in 26 patients (11%).
The mean interval between surgery and diagnosis of an in-
fection was 19 d (median 18 d; range 7–42 d). The pathogenic
micro-organism cultures were coagulase-negative staphylo-
cocci (n = 10), Staphylococcus aureus (n = 8), Acinetobacter
baumannii (n= 1), and Enterococcus faecalis (n = 1). In six
cases, no micro-organism was recovered or no samples were
taken for culture.
The presence of diabetes mellitus (6%), pre-operative local
radiation therapy (5%), immunodeficiency (1%), immuno-
suppressive medication (4%), the number of instrumented
spinal segments (5– 2), and gender were equally distributed in
the group of patients with and without SSI (Table 1). In both
groups, the initial reason for thoracic spine instability was
traumatic in 80% and metastatic disease in 20% (p= 0.617;
Table 1). The duration of surgery was not longer in patients
who presented with an infection at a later date (p= 0.054).
By contrast, there was a significant difference in age between
the two groups, with patients having infection being older
(Table 1).
The SFT was 13– 7mm in patients without SSI and
14 – 6mm in those with an infection. This difference was not
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significant (p = 0.195; Mann-Whitney U test). Thus, further
regression analysis for this factor was abandoned.
Twelve of 26 patients with an SSI (46%) had received pre-
operative blood transfusion, whereas this was the case in
only 47 of 171 patients (22%) without infection (p = 0.006;
Pearson w2). Blood transfusion within 48 h prior to surgery
was confirmed as an independent risk factor for SSI after
posterior fusion for stabilization of thoracic spine trauma by
regression analysis (coefficient B = 1.137; p = 0.009; c sta-
tistic 0.62, 95% CI 0.50–0.74; Wald-Wolfowitz p = 0.31).
The odds ratio (OR) for patients with pre-operative blood
transfusion to present with an SSI was 3.1 (95% CI 1.4–7.2;
p = 0.008). As age older than 60 y also was associated with
incision infection (OR 1.0; 95% CI 1.0–1.1; p=0.100), we
performed a regression analysis that was adjusted for age. In this
age-adjusted analysis, the OR for patients with pre-operative
blood transfusion to sustain an SSI remained 2.7 (95% CI 1.1–
6.4; p = 0.024; Hosmer-Lemeshow p = 0.270; c statistic 0.69;
95% CI 0.59–0.79; Wald-Wolfowitz p = 0.16; Fig. 1).
Patients with a post-operative SSI also had been given a
larger number of pre-operative blood units than patients with-
out infection (1.2–1.7 units vs. 0.7–1.9 units; p= 0.009). By
contrast, therewas no difference between the groupswith regard
to pre-operative hemoglobin concentration (11.9–1.7 g/L vs.
12.1–2.3 g/L; p=0.519) or hematocrit (35.6%–4.8% vs.
35.2%–7.1%; p= 0.908).
Discussion
The purpose of this study was to assess SFT and pre-
operative blood transfusion as independent risk factors for
SSI after posterior fusion for the fixation of thoracic spine
instabilities.
In contrast to a recent study on cervical spine fusion sur-
gery [10], SFT did not seem to play an important role as a risk
factor for infection in the population of the present study. The
main reasons for this might be differences in anatomy be-
tween the cervical and thoracic spine with a different cur-
vature and different muscle–fat ratios. It is possible that SFT
is of importance in areas where there is more soft tissue than
rostral to the thoracic spine [10,19,20].
On the other hand, pre-operative allogeneic blood trans-
fusion proved to be an independent risk factor for SSI, tri-
pling the risk of incisional SSI. This is in line with a recent
large retrospective matched case-control study that reported
an association between SSI after lumbar spine surgery and the
volume of peri-operative allogeneic red blood cell transfu-
sion [14].
Table 1. Patients’ Baseline Characteristics
Infection
Yes No p Total
No. 26 218 244
Age (y [SD]) 61 ( 15) 53 ( 18) 0.021b 54 (17)
Gender (F:M) 11:15 86:132 0.778a 97:147
Duration of surgery (min [SD]) 190 (112) 154 ( 84) .054b 157 (88)
No. of involved spinal segments (SD) 5 ( 2) 5 ( 2) .531b 5 ( 2)
Co-morbidities (%)
Diabetes mellitus 2 ( 8) 13 ( 6) .666a 15 ( 6)
Pre-operative radiation therapy 0 11 ( 5) .24 a 11 ( 5)
Malignant disease 5 ( 19) 42 ( 19) .617a 47 (19)
Immunodeficiency 1 ( 4) 1 (< 1) .997a 2 ( 1)
Immunosuppressive medication 0 9 ( 4) .391a 9 ( 4)
aPearson w2/Fisher exact test.
bMann-Whitney U test.
SD = standard deviation.
FIG. 1. Effect pre-operative blood transfusion and age on surgical site infection rate. (A) Pre-operative blood transfusion
was associated with a higher infection rate independently of age. (B) Older patients (‡ 55 years) were more likely to have a
surgical site infection.
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Other studies on this issue investigated outcomes after
general surgery. An increase in post-operative infection rates
after blood transfusion has been described for patients with
colorectal cancer undergoing surgery [15]. By contrast, a large
study on risk factors for SSI after general surgery could not
find an increase in infections in patients with pre-operative
anemia or transfusion [12].
Spinal incisions may be different from those in general
surgery. The incision cavities after spinal fusion surgery fre-
quently are large and deep, with extensive surfaces. Surgical
site infection, therefore, is more common after spinal fusion
surgery, the rate ranging from 4.5%–17% [4,6,8,21,22] vs.
0.3% to 6.8% in general surgery [12,23,24]. This might be an
explanation for certain risk factors gaining statistical rele-
vance only in patients having spine surgery.
There are three possible mechanisms that could explain the
association of pre-operative allogeneic blood transfusion and
SSI. The first is that patients who required blood transfusions
had previous loss of blood and therefore had lower oxygen and
nutrition transporters to support appropriate healing. As in other
studies on this issue [12,14], the difference between patients
with and without incisional infection with regard to pre-oper-
ative hemoglobin concentration and hematocrit was marginal.
Thus, the hypothesis of an undersupply of oxygen and nutrients
as a result of blood loss is unlikely, at least in institutions with
appropriate peri-operative transfusion management.
In a population of trauma patients or those with metastatic
disease, the second possible mechanism is an immunosup-
pressive effect by the trauma or malignant disease. This has
been described especially for the multiply injured patient [25]
and patients with spinal cord injuries [26]. It is a limitation of
this study that because of the retrospective design, we were
not able to evaluate the severity andmodalities of the injuries.
However, a three- to four-fold higher risk of SSI after pre-
operative allogeneic blood transfusions has been reported
for non-trauma patients as well [14,15]. Metastatic disease
fractures as the cause of spinal instability were not linked
to higher SSI rates, either in our study or in the literature
[27,28]. It might be, however, that the present study under-
estimates the influence of malignant disease on SSI, as 80%
of the cases analyzed were trauma patients rather than those
with malignant disease.
The third possible mechanism of the association of pre-
operative blood transfusion and SSI is an immunosuppressive
effect as a reaction to the allogeneic transfusion itself. This
effect has been discussed to a great extent in the recent lit-
erature [15–17]. As red blood cells lyse during storage of
blood units, free heme is released as a result of hemoglobin
oxidation. As shown in a mouse sepsis model, this free cir-
culating heme increases inflammation and cell death, thereby
compromising host tolerance for infection irrespective of the
amount of circulating heme [29]. In this context, restrictive
transfusion schemes have been able to decrease morbidity
and mortality rates in chronically ill patients with euvolemic
anemia after acute myocardial infarction [30].
Yet trauma patients or those with metastatic malignant
disease undergoing surgery for spinal stabilization are dif-
ferent. Hypovolemic anemia is common in this population,
and transfusion management thus has to take care of both an
appropriate immediate restoration of blood components and
anticipation of future peri-operative and post-operative blood
loss. Patients undergoing spinal surgery with blood loss have
a six-fold higher risk of SSI if their post-operative hemo-
globin concentration is < 8 g/dL [31].
A direct comparison of our results with those of other
studies has to be made with caution. Unlike other studies, the
present study did not assess intra-operative blood loss, as it
was the authors’ opinion that the unmeasurable post-operative
blood loss is of greater importance to the patient’s immune
system.
This study assessed only red blood cell transfusions; trans-
fusions of fresh frozen plasma or other plasma components
were not recorded. However, the transfusion management in
our population of trauma patients followed a fixed algorithm
with emphasis on the substitution of factor concentrates to al-
low a reduction of allogeneic transfusions of red blood cells.
According to the data provided by this study, it is not
possible to recommend a particular transfusion algorithm for
patients who undergo posterior stabilization of thoracic spine
instabilities. Several mechanisms and risk factors may in-
fluence the final probability of an SSI. Other aspects, such as
blood group compatibility or age and grade of lysis of the
blood units, may play an important role and need further
evaluation. However, the results of this study point to factors
that should be further investigated by basic science trials or in
prospective clinical trials with larger subgroup samples.
Conclusion
Subcutaneous fat thickness had no influence on the oc-
currence of SSI after posterior fusion for the fixation of
thoracic spine instabilities, whereas allogeneic red blood cell
transfusion within 48 h prior to surgery was an independent
risk factor for infection. Specifically, pre-operative blood
transfusion tripled the risk of SSI.
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